SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001438533-24-000013
Filing Date
2024-03-27
Accepted
2024-03-27 16:33:54
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFA14A tvtx-2024proxynoticeaccess.htm DEFA14A 44808
2 GRAPHIC internetarrow.jpg GRAPHIC 19807
3 GRAPHIC telephonearrow.jpg GRAPHIC 21818
4 GRAPHIC e-mlarrow.jpg GRAPHIC 18952
  Complete submission text file 0001438533-24-000013.txt   129852
Mailing Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130 888-969-7879
Travere Therapeutics, Inc. (Filer) CIK: 0001438533 (see all company filings)

IRS No.: 262383102 | State of Incorp.: CA | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36257 | Film No.: 24791326
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)